Comparison of flow cytometry and next-generation sequencing in minimal residual disease monitoring of acute myeloid leukemia: One institute's practical clinical experience

CONCLUSION: Our findings show that flow cytometry has its advantages with comparable sensitivity in detecting minimal/measurable residual disease. Next-generation sequencing could be used in an increased and more regular capacity in conjunction with flow cytometry to achieve a more comprehensive surveillance of these patients, resulting in improved outcomes.PMID:34585519 | DOI:10.1111/ijlh.13711

Source: International Journal of Laboratory Hematology - September 29, 2021 Category: Hematology Authors: Paul F McGowan Stephen D Hyter Wei Cui Regina M Plummer Andrew K Godwin Da Zhang Source Type: research